MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sales or
maturities of investments
$27,495K
Proceeds from exercise of
common warrants
$2,446K
Proceeds from common
stock issuances under...
$143K
Proceeds from exercise of
stock options
$9K
Net cash provided by
investing activities
$27,460K
Net cash provided by
financing activities
$2,452K
Canceled cashflow
$35K
Canceled cashflow
$146K
Net change in cash,
cash equivalents and...
$8,768K
Canceled cashflow
$21,144K
Purchase of property and
equipment
$35K
Stock based
compensation expense
$2,755K
Reduction in the carrying
amount of rou assets,...
$393K
Reduction in the carrying
amount of rou assets,...
$80K
Depreciation and
amortization expense
$73K
Lease liabilities,
finance
$2K
Payments on finance
leases
$121K
Third-party commissions and
offering costs incurred...
$25K
Net cash used in
operating activities
-$21,144K
Canceled cashflow
$3,303K
Net loss
-$20,196K
Accounts payable
-$1,596K
Prepaid expenses and
other current assets
$1,119K
Accrued expenses and
other current...
-$1,092K
Lease liabilities,
operating
-$402K
Amortization of premium
(accretion of discount) on...
$42K
Back
Back
Cash Flow
Lexeo Therapeutics, Inc. (LXEO)
Lexeo Therapeutics, Inc. (LXEO)
source: myfinsight.com